Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

“When a celebrity talks about their experience with an illness or condition, it not only sparks gossip and a sense of ...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

GLP-1 agonists have gained recent widespread attention, reshaping treatment approaches for several diseases, including diabetes and cardiovascular disease. 2 In the treatment of type 2 diabetes, ...

The insidious onset and slow progression of symptoms may cause delay in the recognition of trigeminal schwannomas. Two cases with abducens nerve palsy as an initial symptom are reported, in both of ...

Most human herpesviruses are neurotropic and have the capability to cause serious acute and chronic neurological diseases of the nervous system. In this article, Gilden et al. review current ...

References: Ferrer receives FDA Fast Track designation for FNP-223 in progressive supranuclear palsy (PSP). News release. Ferrer. June 17, 2025.

This review explores the hypothesis that dysfunction of neural mechanisms that mediate trigeminovascular activation are at the root of migraine. Could this be a fruitful target for drug development?